The Juncture Between Clostridioides difficile Infection and Inflammatory Bowel Diseases. Clin Infect Dis 2019 Jul 02;69(2):366-372
Date
01/29/2019Pubmed ID
30689770DOI
10.1093/cid/ciz061Scopus ID
2-s2.0-85069263875 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
The detection of Clostridioides difficile in inflammatory bowel disease (IBD) patients is a common occurrence, in part due to the standard clinical practice of testing for the presence of C. difficile during acute IBD exacerbations. Given the clinical overlap between C. difficile infections and acute IBD exacerbations (ie, increased frequency of loose stools, abdominal pain), it is hard to differentiate C. difficile infections versus colonizations in patients with underlying IBD who test positive for C. difficile. Here, we review the epidemiology, clinical presentation, risk factors, diagnosis, treatment, and outcomes of IBD patients with positive C. difficile tests.
Author List
Beniwal-Patel P, Stein DJ, Munoz-Price LSAuthors
Poonam Beniwal-Patel MD Associate Professor in the Medicine department at Medical College of WisconsinDaniel J. Stein MD Director, Associate Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Carrier StateClostridium Infections
Disease Management
Humans
Inflammatory Bowel Diseases
Risk Factors